ZH501-VSVRI: Is it still the best choice for vaccination against Rift valley fever in Egypt?

Journal of Vaccines and Vaccination

Volumn 2, Issue 3, 2011, Pages

  Atwa, Mohamed H ^a   El Sabagh, Ibrahim M ^b,c   Amer, Haitham M ^b,d   Saad, Samy ^a   Yousif, Ausama A ^b   Shalaby, Mohamed A ^b  

^a Agricultural Research Center   (Egypt)

^b Cairo University   (Egypt)

^c KING FAISAL UNIVERSITY   (Saudi Arabia)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Egypt; RVFV; Vaccine; ZH501 VRVSI strain

Indexed keywords

EID: 84865293620     PISSN: None     EISSN: 21577560     Source Type: Journal    
DOI: 10.4172/2157-7560.1000121     Document Type: Article

References (30)

1. Morrill JC, McClain DJ (1996) Epidemiology and pathogenesis of Rift Valley fever and other phleboviruses. In Elliott RM (eds); The Bunyaviridae. Plenum press, New York, pp 281-293.
2. Zeller HG, Fontenille D, Traore-Lamizana M, Thiongane Y, Digoutte JP (2000) Enzootic activity of Rift Valley fever virus in Senegal. Am J Trop Med Hyg 56: 265-272.
3. Swanepoel R, Coetzer JA (2004) Rift Valley fever. In Coetzer JA, Tustin RC (eds); Infectious diseases of livestock. Oxford University Press Southern Africa, Cape Town, 1037-1070.
4. Daubney R, Hudson JR, Graham PC (1931) Enzootic hepatitis or Rift Valley Fever. Undescribed virus diseases of sheep, cattle and man from East Africa. J Pathol Bacteriol 43: 545-579.
5. Daubney R, Hudson JR (1932) Rift Valley fever. Lancet 1: 611-612.
6. Gredes GH (2004) Rift Valley fever. Rev Sci Tech Off Int Epizoot 23: 613-623.
7. El-Akkad AM (1978) Rift Valley Fever outbreak in Egypt. October--December 1977. J Egypt Public Health Assoc 111: 123-128.
8. Imam ZE, Darwish MA, El-Karamany RE (1978) Epidemic of Rift Valley Fever imn Egypt. Virological diagnosis of RVF in man. J Egyptian Public Health Assoc 111: 205-208.
9. Arthur RR, El Sharkawy MS, Cope SE, Botros BA, Oun S, et al (1993) Reoccurrence of Rift Valley Fever in Egypt. Lancet 342: 1149-1150.
10. Giorgi C (1996) Molecular biology of phleboviruses. In Elliott RM (ed); The Bunyaviridae. Plenum Press, New York 105-128.
11. Schmaljhon C (1996) Bunyaviridae: the viruses and their replication. In Fields BN, Knipe DM, Howley PM (eds); Fields Virology (3rd edn). Lippincott Raven Publishers, Philadelphia 1447-1471.
12. Kakach LT, Suzich JA, Collett MS (1989) Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation. Virology 170: 505-510.
13. Suzich JA, Kakach LT, Collett MS (1990) Expression strategy of a phlebovirus: biogenesis of proteins from the Rift valley fever virus M segment. J Virol 64: 1549-1555.
14. Gerrard SR, Nichol ST (2007) Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins. Virology 357: 124-133.
15. Smithburn KC (1949) Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine. Brit J Exp Pathol 30: 1-16.
16. Botros B, Omar A, Elian K, Mohamed G, Soliman S, et al. (2006) Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine. J Med Virol 78: 787-791.
17. Kamal SA (2009) Pathological studies on postvaccinal reactions of Rift Valley fever in goats. Virol J 6: 94.
18. Barnard BJ, Botha MJ (1977) An inactivated Rift Valley fever vaccine. J S Afr Vet Assoc 48: 45-157.
19. El-Nimr MM (1980) Studies on the inactivated vaccine against Rift Valley Fever. PhD Thesis, Fac Vet Med, Assuit Univ, Egypt.
20. Morrill JC, Ikegami T, Yoshikawa-Iwata N, Lokugamage N, Won S, et al. (2010) Rapid accumulation of virulent Rift Valley fever virus in mice from an attenuated virus carrying nucleotide substitution in the M RNA. PLos One 5: e9986.
21. Won A, Ikegami T, Peters CJ, Mahino S (2007) NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J Virol 81: 13335-13345.
22. Shoemaker T, Boulianne C, Vincent MJ, Pezzanite L, Al-Qahtani MM, et al. (2002) Genetic analysis of viruses associated with emergence of Rift Valley Fever in Saudi Arabia and Yemen, 2000-2001. Emerg Infect Dis 8: 1415-1420.
23. CDC (2007) Rift Valley Fever. CDC Special Pathogens Branch.
24. Meegan JM, Hoogstraal H, Moussa MI (1977) An epizootic of Rift Valley in Egypt in 1977. Vet Rec 105: 124-125.
25. Ikegamia T, Makino S (2009) Rift Valley fever vaccines. Vaccine 27: D69-D72.
26. Office International Des Epizooties (OIE) (2008) Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (Mammals, Birds and Bees) (6th ed), Editions of the OIE Biological Standards Commission, Paris.
27. Muller R, Saluzzo JF, Lopez N, Dreier T, Turrell M, et al. (1995) Characterization of clone 13-a naturally attenuated avirulent isolate of Rift Valley fever virus which is altered in the small segment. Am J Trop Med Hyg 53: 405-411.
28. Vialat P, Billecocq A, Kohl A, Bouloy M (2000) The S Segment of Rift Valley Fever Phlebovirus (Bunyaviridae) Carries Determinants for Attenuation and Virulence in Mice. J Virol 74: 1538-1543.
29. Imam ZE, El-Karanmany R, Omar F, El-Kafrawy O (1981) Rift Valley fever in Egypt. J Egypt Public Health Assoc 56: 356-383.
30. Meegan JM (1979) The Rift Valley fever epizootic in Egypt 1977-78. 1. description of the epizootic and virologic studies. Trans R Soc Trop Med Hyg 73: 618-623.